Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Xymoflam SP 50mg/325mg/15mg Tablet

Prescription Icon
Prescription Required

Marketer

Aristo Pharmaceuticals Pvt Ltd

Salt Composition

Diclofenac (50mg) + Paracetamol (325mg) + Serratiopeptidase (15mg)

Overview Xymoflam SP 50mg/325mg/15mg Tablet

Combiflam Rx 50mg/325mg/15mg tablets offer effective pain relief and fever reduction. This medication targets moderate pain stemming from diverse sources including muscular aches, back pain, arthritic discomfort, menstrual cramps, and dental pain. For optimal absorption and to minimize gastrointestinal upset, take Combiflam Rx with food. Dosage and treatment length are determined by individual needs and response. Continue medication as directed by your physician, even after symptom improvement, until advised otherwise. Common side effects, such as nausea, vomiting, abdominal pain, indigestion, and heartburn, may occur. Persistent or worsening side effects require immediate medical attention. Minimize dosage to manage symptoms effectively. Inform your doctor about existing health conditions or other medications before commencing treatment. Individuals with liver or kidney disease, or those with alcohol dependence, should exercise caution. Pregnant or breastfeeding individuals must consult their doctor before use.

Uses of Xymoflam SP 50mg/325mg/15mg Tablet

Analgesia

Major Benefits of Xymoflam SP 50mg/325mg/15mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the Xymoflam SP 50mg/325mg/15mg Tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.

Common Side effects of Xymoflam SP 50mg/325mg/15mg Tablet:

  • Nausea
  • Vomiting
  • Stomach pain
  • Indigestion
  • Heartburn
  • Loss of appetite
  • Diarrhea

How to use Xymoflam SP 50mg/325mg/15mg Tablet:

Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Ingest the Xymoflam SP 50mg/325mg/15mg Tablet whole; avoid crushing, chewing, or breaking it. Administer this tablet with a meal.

How Xymoflam SP 50mg/325mg/15mg Tablet works:

Each Xymoflam SP 50mg/325mg/15mg tablet combines diclofenac, paracetamol, and serratiopeptidase to alleviate pain. Diclofenac, a non-steroidal anti-inflammatory drug (NSAID), and the antipyretic paracetamol, reduce pain and fever by inhibiting the production of pain- and fever-inducing brain chemicals. Serratiopeptidase, an enzyme, aids healing by degrading inflammatory proteins.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Xymoflam SP 50mg/325mg/15mg tablets is not advisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Xymoflam SP 50mg/325mg/15mg tablets is contraindicated during pregnancy due to established fetal risk. In exceptional, life-threatening circumstances, a physician might prescribe it when the potential benefits outweigh the known hazards. Always seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Data on the use of Xymoflam SP 50mg/325mg/15mg tablets while breastfeeding is lacking. Seek your physician's advice.

DrivingDrivingUNSAFE

Driving ability may be impaired by Xymoflam SP 50mg/325mg/15mg Tablets, which can induce side effects such as headaches, blurred vision, dizziness, or drowsiness in certain individuals.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Xymoflam SP 50mg/325mg/15mg tablets. Dosage modification may be necessary; physician consultation is recommended.

LiverLiverCAUTION

Patients with liver impairment should use Xymoflam SP 50mg/325mg/15mg tablets cautiously, potentially requiring dosage modification. Consult a physician before use. Xymoflam SP 50mg/325mg/15mg tablets are contraindicated in patients with severe or active liver disease.

What if you forget to take Xymoflam SP 50mg/325mg/15mg Tablet :

Should you forget to take a Xymoflam SP 50mg/325mg/15mg Tablet, administer it immediately upon remembrance. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Xymoflam SP 50mg/325mg/15mg Tablet

LabelValue
Potential for Dependence None.
Medication Classification Medications for Pain Relief

FAQs on Xymoflam SP 50mg/325mg/15mg Tablet

Store this medication in its original, tightly sealed container, following the storage instructions provided on the packaging. Discard any leftover medication properly. Ensure the medication remains inaccessible to children, pets, and other individuals.
Diclofenac, paracetamol, and serratiopeptidase combine in Xymoflam SP 50mg/325mg/15mg tablets to alleviate pain and inflammation. The medication achieves this effect by reducing the concentration of inflammatory and pain-inducing compounds within the body.
Xymoflam SP 50mg/325mg/15mg Tablets are generally well-tolerated; however, some individuals may experience side effects such as nausea, vomiting, abdominal pain, dyspepsia, and diarrhea. Promptly report any ongoing medication-related issues to your physician.
The Xymoflam SP 50mg/325mg/15mg Tablet is typically prescribed for short-term use, ceasing when pain subsides. Physician guidance should be followed regarding continued use of the Xymoflam SP 50mg/325mg/15mg Tablet.
Nausea and vomiting are potential side effects of Xymoflam SP 50mg/325mg/15mg Tablets. Ingesting the tablets with milk, food, or antacids may mitigate nausea. Fatty or fried foods should be avoided while taking this medication. If vomiting occurs, replenish fluids by sipping small amounts of water or other liquids frequently. Consult your physician if vomiting continues or if dehydration symptoms—such as dark, concentrated urine, infrequent urination—appear. Always discuss any other medications with your doctor before taking them.
Indeed, $ame may induce dizziness in certain individuals, manifesting as faintness, weakness, unsteadiness, or lightheadedness. Should dizziness or lightheadedness occur, rest is recommended until symptoms subside. Operating machinery or driving should be avoided during this time.
Xymoflam SP 50mg/325mg/15mg Tablets are contraindicated in individuals with hypersensitivity to any constituent or inactive ingredient, or those exhibiting hypersensitivity to other nonsteroidal anti-inflammatory drugs (NSAIDs). This medication should be used cautiously, or ideally avoided, by patients with a history of peptic ulcers, active or recurrent ulceration/bleeding, heart failure, hypertension, or hepatic or renal impairment.
Concurrent use of Xymoflam SP 50mg/325mg/15mg tablets and vitamin B-complex supplements is permissible. The Xymoflam SP 50mg/325mg/15mg tablet offers pain relief, while the vitamin B-complex addresses potential vitamin deficiencies contributing to the patient's discomfort.
Taking Xymoflam SP 50mg/325mg/15mg tablets for stomach pain is not recommended without first seeking medical advice. This medication potentially elevates stomach acid production, possibly worsening undiagnosed issues.
Exceeding the prescribed dosage of Xymoflam SP 50mg/325mg/15mg Tablets elevates the risk of adverse reactions. Should your pain worsen or fail to respond to the recommended dose, seek medical advice for reassessment.
Xymoflam SP 50mg/325mg/15...
111
MRP 135
17% off